Global Next-Generation Immunology Drugs Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Next-Generation Immunology Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Next-Generation Immunology Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Next-Generation Immunology Drugs market size and forecasts, in consumption value ($ Million), 2018-2029
Global Next-Generation Immunology Drugs market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Next-Generation Immunology Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Next-Generation Immunology Drugs market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Next-Generation Immunology Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Next-Generation Immunology Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer Inc, Abbvie Inc., Johnson and Johnson, F. Hoffmann-La Roche Ltd. and Amgen Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Next-Generation Immunology Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Next-Generation Immunology Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Next-Generation Immunology Drugs, with revenue, gross margin and global market share of Next-Generation Immunology Drugs from 2018 to 2023.
Chapter 3, the Next-Generation Immunology Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Next-Generation Immunology Drugs market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Next-Generation Immunology Drugs.
Chapter 13, to describe Next-Generation Immunology Drugs research findings and conclusion.
This report is a detailed and comprehensive analysis for global Next-Generation Immunology Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Next-Generation Immunology Drugs market size and forecasts, in consumption value ($ Million), 2018-2029
Global Next-Generation Immunology Drugs market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Next-Generation Immunology Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Next-Generation Immunology Drugs market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Next-Generation Immunology Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Next-Generation Immunology Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer Inc, Abbvie Inc., Johnson and Johnson, F. Hoffmann-La Roche Ltd. and Amgen Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Next-Generation Immunology Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Cell Therapy
- Small Molecule Drug
- Others
- Hospital
- Clinic
- Others
- Pfizer Inc
- Abbvie Inc.
- Johnson and Johnson
- F. Hoffmann-La Roche Ltd.
- Amgen Inc.
- Novartis AG
- Astellas Pharma Inc.
- Bristol-Myers Squibb Company
- Merck & Co., Inc.
- Eli Lilly and Company
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Next-Generation Immunology Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Next-Generation Immunology Drugs, with revenue, gross margin and global market share of Next-Generation Immunology Drugs from 2018 to 2023.
Chapter 3, the Next-Generation Immunology Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Next-Generation Immunology Drugs market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Next-Generation Immunology Drugs.
Chapter 13, to describe Next-Generation Immunology Drugs research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Next-Generation Immunology Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Next-Generation Immunology Drugs by Type
1.3.1 Overview: Global Next-Generation Immunology Drugs Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Next-Generation Immunology Drugs Consumption Value Market Share by Type in 2022
1.3.3 Cell Therapy
1.3.4 Small Molecule Drug
1.3.5 Others
1.4 Global Next-Generation Immunology Drugs Market by Application
1.4.1 Overview: Global Next-Generation Immunology Drugs Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Others
1.5 Global Next-Generation Immunology Drugs Market Size & Forecast
1.6 Global Next-Generation Immunology Drugs Market Size and Forecast by Region
1.6.1 Global Next-Generation Immunology Drugs Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Next-Generation Immunology Drugs Market Size by Region, (2018-2029)
1.6.3 North America Next-Generation Immunology Drugs Market Size and Prospect (2018-2029)
1.6.4 Europe Next-Generation Immunology Drugs Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Next-Generation Immunology Drugs Market Size and Prospect (2018-2029)
1.6.6 South America Next-Generation Immunology Drugs Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Next-Generation Immunology Drugs Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Pfizer Inc
2.1.1 Pfizer Inc Details
2.1.2 Pfizer Inc Major Business
2.1.3 Pfizer Inc Next-Generation Immunology Drugs Product and Solutions
2.1.4 Pfizer Inc Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Pfizer Inc Recent Developments and Future Plans
2.2 Abbvie Inc.
2.2.1 Abbvie Inc. Details
2.2.2 Abbvie Inc. Major Business
2.2.3 Abbvie Inc. Next-Generation Immunology Drugs Product and Solutions
2.2.4 Abbvie Inc. Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Abbvie Inc. Recent Developments and Future Plans
2.3 Johnson and Johnson
2.3.1 Johnson and Johnson Details
2.3.2 Johnson and Johnson Major Business
2.3.3 Johnson and Johnson Next-Generation Immunology Drugs Product and Solutions
2.3.4 Johnson and Johnson Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Johnson and Johnson Recent Developments and Future Plans
2.4 F. Hoffmann-La Roche Ltd.
2.4.1 F. Hoffmann-La Roche Ltd. Details
2.4.2 F. Hoffmann-La Roche Ltd. Major Business
2.4.3 F. Hoffmann-La Roche Ltd. Next-Generation Immunology Drugs Product and Solutions
2.4.4 F. Hoffmann-La Roche Ltd. Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 F. Hoffmann-La Roche Ltd. Recent Developments and Future Plans
2.5 Amgen Inc.
2.5.1 Amgen Inc. Details
2.5.2 Amgen Inc. Major Business
2.5.3 Amgen Inc. Next-Generation Immunology Drugs Product and Solutions
2.5.4 Amgen Inc. Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Amgen Inc. Recent Developments and Future Plans
2.6 Novartis AG
2.6.1 Novartis AG Details
2.6.2 Novartis AG Major Business
2.6.3 Novartis AG Next-Generation Immunology Drugs Product and Solutions
2.6.4 Novartis AG Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Novartis AG Recent Developments and Future Plans
2.7 Astellas Pharma Inc.
2.7.1 Astellas Pharma Inc. Details
2.7.2 Astellas Pharma Inc. Major Business
2.7.3 Astellas Pharma Inc. Next-Generation Immunology Drugs Product and Solutions
2.7.4 Astellas Pharma Inc. Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Astellas Pharma Inc. Recent Developments and Future Plans
2.8 Bristol-Myers Squibb Company
2.8.1 Bristol-Myers Squibb Company Details
2.8.2 Bristol-Myers Squibb Company Major Business
2.8.3 Bristol-Myers Squibb Company Next-Generation Immunology Drugs Product and Solutions
2.8.4 Bristol-Myers Squibb Company Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Bristol-Myers Squibb Company Recent Developments and Future Plans
2.9 Merck & Co., Inc.
2.9.1 Merck & Co., Inc. Details
2.9.2 Merck & Co., Inc. Major Business
2.9.3 Merck & Co., Inc. Next-Generation Immunology Drugs Product and Solutions
2.9.4 Merck & Co., Inc. Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Merck & Co., Inc. Recent Developments and Future Plans
2.10 Eli Lilly and Company
2.10.1 Eli Lilly and Company Details
2.10.2 Eli Lilly and Company Major Business
2.10.3 Eli Lilly and Company Next-Generation Immunology Drugs Product and Solutions
2.10.4 Eli Lilly and Company Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Eli Lilly and Company Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Next-Generation Immunology Drugs Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Next-Generation Immunology Drugs by Company Revenue
3.2.2 Top 3 Next-Generation Immunology Drugs Players Market Share in 2022
3.2.3 Top 6 Next-Generation Immunology Drugs Players Market Share in 2022
3.3 Next-Generation Immunology Drugs Market: Overall Company Footprint Analysis
3.3.1 Next-Generation Immunology Drugs Market: Region Footprint
3.3.2 Next-Generation Immunology Drugs Market: Company Product Type Footprint
3.3.3 Next-Generation Immunology Drugs Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Next-Generation Immunology Drugs Consumption Value and Market Share by Type (2018-2023)
4.2 Global Next-Generation Immunology Drugs Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Next-Generation Immunology Drugs Consumption Value Market Share by Application (2018-2023)
5.2 Global Next-Generation Immunology Drugs Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Next-Generation Immunology Drugs Consumption Value by Type (2018-2029)
6.2 North America Next-Generation Immunology Drugs Consumption Value by Application (2018-2029)
6.3 North America Next-Generation Immunology Drugs Market Size by Country
6.3.1 North America Next-Generation Immunology Drugs Consumption Value by Country (2018-2029)
6.3.2 United States Next-Generation Immunology Drugs Market Size and Forecast (2018-2029)
6.3.3 Canada Next-Generation Immunology Drugs Market Size and Forecast (2018-2029)
6.3.4 Mexico Next-Generation Immunology Drugs Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Next-Generation Immunology Drugs Consumption Value by Type (2018-2029)
7.2 Europe Next-Generation Immunology Drugs Consumption Value by Application (2018-2029)
7.3 Europe Next-Generation Immunology Drugs Market Size by Country
7.3.1 Europe Next-Generation Immunology Drugs Consumption Value by Country (2018-2029)
7.3.2 Germany Next-Generation Immunology Drugs Market Size and Forecast (2018-2029)
7.3.3 France Next-Generation Immunology Drugs Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Next-Generation Immunology Drugs Market Size and Forecast (2018-2029)
7.3.5 Russia Next-Generation Immunology Drugs Market Size and Forecast (2018-2029)
7.3.6 Italy Next-Generation Immunology Drugs Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Next-Generation Immunology Drugs Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Next-Generation Immunology Drugs Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Next-Generation Immunology Drugs Market Size by Region
8.3.1 Asia-Pacific Next-Generation Immunology Drugs Consumption Value by Region (2018-2029)
8.3.2 China Next-Generation Immunology Drugs Market Size and Forecast (2018-2029)
8.3.3 Japan Next-Generation Immunology Drugs Market Size and Forecast (2018-2029)
8.3.4 South Korea Next-Generation Immunology Drugs Market Size and Forecast (2018-2029)
8.3.5 India Next-Generation Immunology Drugs Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Next-Generation Immunology Drugs Market Size and Forecast (2018-2029)
8.3.7 Australia Next-Generation Immunology Drugs Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Next-Generation Immunology Drugs Consumption Value by Type (2018-2029)
9.2 South America Next-Generation Immunology Drugs Consumption Value by Application (2018-2029)
9.3 South America Next-Generation Immunology Drugs Market Size by Country
9.3.1 South America Next-Generation Immunology Drugs Consumption Value by Country (2018-2029)
9.3.2 Brazil Next-Generation Immunology Drugs Market Size and Forecast (2018-2029)
9.3.3 Argentina Next-Generation Immunology Drugs Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Next-Generation Immunology Drugs Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Next-Generation Immunology Drugs Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Next-Generation Immunology Drugs Market Size by Country
10.3.1 Middle East & Africa Next-Generation Immunology Drugs Consumption Value by Country (2018-2029)
10.3.2 Turkey Next-Generation Immunology Drugs Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Next-Generation Immunology Drugs Market Size and Forecast (2018-2029)
10.3.4 UAE Next-Generation Immunology Drugs Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Next-Generation Immunology Drugs Market Drivers
11.2 Next-Generation Immunology Drugs Market Restraints
11.3 Next-Generation Immunology Drugs Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Next-Generation Immunology Drugs Industry Chain
12.2 Next-Generation Immunology Drugs Upstream Analysis
12.3 Next-Generation Immunology Drugs Midstream Analysis
12.4 Next-Generation Immunology Drugs Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Next-Generation Immunology Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Next-Generation Immunology Drugs by Type
1.3.1 Overview: Global Next-Generation Immunology Drugs Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Next-Generation Immunology Drugs Consumption Value Market Share by Type in 2022
1.3.3 Cell Therapy
1.3.4 Small Molecule Drug
1.3.5 Others
1.4 Global Next-Generation Immunology Drugs Market by Application
1.4.1 Overview: Global Next-Generation Immunology Drugs Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Others
1.5 Global Next-Generation Immunology Drugs Market Size & Forecast
1.6 Global Next-Generation Immunology Drugs Market Size and Forecast by Region
1.6.1 Global Next-Generation Immunology Drugs Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Next-Generation Immunology Drugs Market Size by Region, (2018-2029)
1.6.3 North America Next-Generation Immunology Drugs Market Size and Prospect (2018-2029)
1.6.4 Europe Next-Generation Immunology Drugs Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Next-Generation Immunology Drugs Market Size and Prospect (2018-2029)
1.6.6 South America Next-Generation Immunology Drugs Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Next-Generation Immunology Drugs Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Pfizer Inc
2.1.1 Pfizer Inc Details
2.1.2 Pfizer Inc Major Business
2.1.3 Pfizer Inc Next-Generation Immunology Drugs Product and Solutions
2.1.4 Pfizer Inc Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Pfizer Inc Recent Developments and Future Plans
2.2 Abbvie Inc.
2.2.1 Abbvie Inc. Details
2.2.2 Abbvie Inc. Major Business
2.2.3 Abbvie Inc. Next-Generation Immunology Drugs Product and Solutions
2.2.4 Abbvie Inc. Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Abbvie Inc. Recent Developments and Future Plans
2.3 Johnson and Johnson
2.3.1 Johnson and Johnson Details
2.3.2 Johnson and Johnson Major Business
2.3.3 Johnson and Johnson Next-Generation Immunology Drugs Product and Solutions
2.3.4 Johnson and Johnson Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Johnson and Johnson Recent Developments and Future Plans
2.4 F. Hoffmann-La Roche Ltd.
2.4.1 F. Hoffmann-La Roche Ltd. Details
2.4.2 F. Hoffmann-La Roche Ltd. Major Business
2.4.3 F. Hoffmann-La Roche Ltd. Next-Generation Immunology Drugs Product and Solutions
2.4.4 F. Hoffmann-La Roche Ltd. Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 F. Hoffmann-La Roche Ltd. Recent Developments and Future Plans
2.5 Amgen Inc.
2.5.1 Amgen Inc. Details
2.5.2 Amgen Inc. Major Business
2.5.3 Amgen Inc. Next-Generation Immunology Drugs Product and Solutions
2.5.4 Amgen Inc. Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Amgen Inc. Recent Developments and Future Plans
2.6 Novartis AG
2.6.1 Novartis AG Details
2.6.2 Novartis AG Major Business
2.6.3 Novartis AG Next-Generation Immunology Drugs Product and Solutions
2.6.4 Novartis AG Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Novartis AG Recent Developments and Future Plans
2.7 Astellas Pharma Inc.
2.7.1 Astellas Pharma Inc. Details
2.7.2 Astellas Pharma Inc. Major Business
2.7.3 Astellas Pharma Inc. Next-Generation Immunology Drugs Product and Solutions
2.7.4 Astellas Pharma Inc. Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Astellas Pharma Inc. Recent Developments and Future Plans
2.8 Bristol-Myers Squibb Company
2.8.1 Bristol-Myers Squibb Company Details
2.8.2 Bristol-Myers Squibb Company Major Business
2.8.3 Bristol-Myers Squibb Company Next-Generation Immunology Drugs Product and Solutions
2.8.4 Bristol-Myers Squibb Company Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Bristol-Myers Squibb Company Recent Developments and Future Plans
2.9 Merck & Co., Inc.
2.9.1 Merck & Co., Inc. Details
2.9.2 Merck & Co., Inc. Major Business
2.9.3 Merck & Co., Inc. Next-Generation Immunology Drugs Product and Solutions
2.9.4 Merck & Co., Inc. Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Merck & Co., Inc. Recent Developments and Future Plans
2.10 Eli Lilly and Company
2.10.1 Eli Lilly and Company Details
2.10.2 Eli Lilly and Company Major Business
2.10.3 Eli Lilly and Company Next-Generation Immunology Drugs Product and Solutions
2.10.4 Eli Lilly and Company Next-Generation Immunology Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Eli Lilly and Company Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Next-Generation Immunology Drugs Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Next-Generation Immunology Drugs by Company Revenue
3.2.2 Top 3 Next-Generation Immunology Drugs Players Market Share in 2022
3.2.3 Top 6 Next-Generation Immunology Drugs Players Market Share in 2022
3.3 Next-Generation Immunology Drugs Market: Overall Company Footprint Analysis
3.3.1 Next-Generation Immunology Drugs Market: Region Footprint
3.3.2 Next-Generation Immunology Drugs Market: Company Product Type Footprint
3.3.3 Next-Generation Immunology Drugs Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Next-Generation Immunology Drugs Consumption Value and Market Share by Type (2018-2023)
4.2 Global Next-Generation Immunology Drugs Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Next-Generation Immunology Drugs Consumption Value Market Share by Application (2018-2023)
5.2 Global Next-Generation Immunology Drugs Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Next-Generation Immunology Drugs Consumption Value by Type (2018-2029)
6.2 North America Next-Generation Immunology Drugs Consumption Value by Application (2018-2029)
6.3 North America Next-Generation Immunology Drugs Market Size by Country
6.3.1 North America Next-Generation Immunology Drugs Consumption Value by Country (2018-2029)
6.3.2 United States Next-Generation Immunology Drugs Market Size and Forecast (2018-2029)
6.3.3 Canada Next-Generation Immunology Drugs Market Size and Forecast (2018-2029)
6.3.4 Mexico Next-Generation Immunology Drugs Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Next-Generation Immunology Drugs Consumption Value by Type (2018-2029)
7.2 Europe Next-Generation Immunology Drugs Consumption Value by Application (2018-2029)
7.3 Europe Next-Generation Immunology Drugs Market Size by Country
7.3.1 Europe Next-Generation Immunology Drugs Consumption Value by Country (2018-2029)
7.3.2 Germany Next-Generation Immunology Drugs Market Size and Forecast (2018-2029)
7.3.3 France Next-Generation Immunology Drugs Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Next-Generation Immunology Drugs Market Size and Forecast (2018-2029)
7.3.5 Russia Next-Generation Immunology Drugs Market Size and Forecast (2018-2029)
7.3.6 Italy Next-Generation Immunology Drugs Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Next-Generation Immunology Drugs Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Next-Generation Immunology Drugs Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Next-Generation Immunology Drugs Market Size by Region
8.3.1 Asia-Pacific Next-Generation Immunology Drugs Consumption Value by Region (2018-2029)
8.3.2 China Next-Generation Immunology Drugs Market Size and Forecast (2018-2029)
8.3.3 Japan Next-Generation Immunology Drugs Market Size and Forecast (2018-2029)
8.3.4 South Korea Next-Generation Immunology Drugs Market Size and Forecast (2018-2029)
8.3.5 India Next-Generation Immunology Drugs Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Next-Generation Immunology Drugs Market Size and Forecast (2018-2029)
8.3.7 Australia Next-Generation Immunology Drugs Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Next-Generation Immunology Drugs Consumption Value by Type (2018-2029)
9.2 South America Next-Generation Immunology Drugs Consumption Value by Application (2018-2029)
9.3 South America Next-Generation Immunology Drugs Market Size by Country
9.3.1 South America Next-Generation Immunology Drugs Consumption Value by Country (2018-2029)
9.3.2 Brazil Next-Generation Immunology Drugs Market Size and Forecast (2018-2029)
9.3.3 Argentina Next-Generation Immunology Drugs Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Next-Generation Immunology Drugs Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Next-Generation Immunology Drugs Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Next-Generation Immunology Drugs Market Size by Country
10.3.1 Middle East & Africa Next-Generation Immunology Drugs Consumption Value by Country (2018-2029)
10.3.2 Turkey Next-Generation Immunology Drugs Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Next-Generation Immunology Drugs Market Size and Forecast (2018-2029)
10.3.4 UAE Next-Generation Immunology Drugs Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Next-Generation Immunology Drugs Market Drivers
11.2 Next-Generation Immunology Drugs Market Restraints
11.3 Next-Generation Immunology Drugs Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Next-Generation Immunology Drugs Industry Chain
12.2 Next-Generation Immunology Drugs Upstream Analysis
12.3 Next-Generation Immunology Drugs Midstream Analysis
12.4 Next-Generation Immunology Drugs Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Next-Generation Immunology Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Next-Generation Immunology Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Next-Generation Immunology Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Next-Generation Immunology Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Pfizer Inc Company Information, Head Office, and Major Competitors
Table 6. Pfizer Inc Major Business
Table 7. Pfizer Inc Next-Generation Immunology Drugs Product and Solutions
Table 8. Pfizer Inc Next-Generation Immunology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Pfizer Inc Recent Developments and Future Plans
Table 10. Abbvie Inc. Company Information, Head Office, and Major Competitors
Table 11. Abbvie Inc. Major Business
Table 12. Abbvie Inc. Next-Generation Immunology Drugs Product and Solutions
Table 13. Abbvie Inc. Next-Generation Immunology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Abbvie Inc. Recent Developments and Future Plans
Table 15. Johnson and Johnson Company Information, Head Office, and Major Competitors
Table 16. Johnson and Johnson Major Business
Table 17. Johnson and Johnson Next-Generation Immunology Drugs Product and Solutions
Table 18. Johnson and Johnson Next-Generation Immunology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Johnson and Johnson Recent Developments and Future Plans
Table 20. F. Hoffmann-La Roche Ltd. Company Information, Head Office, and Major Competitors
Table 21. F. Hoffmann-La Roche Ltd. Major Business
Table 22. F. Hoffmann-La Roche Ltd. Next-Generation Immunology Drugs Product and Solutions
Table 23. F. Hoffmann-La Roche Ltd. Next-Generation Immunology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. F. Hoffmann-La Roche Ltd. Recent Developments and Future Plans
Table 25. Amgen Inc. Company Information, Head Office, and Major Competitors
Table 26. Amgen Inc. Major Business
Table 27. Amgen Inc. Next-Generation Immunology Drugs Product and Solutions
Table 28. Amgen Inc. Next-Generation Immunology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Amgen Inc. Recent Developments and Future Plans
Table 30. Novartis AG Company Information, Head Office, and Major Competitors
Table 31. Novartis AG Major Business
Table 32. Novartis AG Next-Generation Immunology Drugs Product and Solutions
Table 33. Novartis AG Next-Generation Immunology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Novartis AG Recent Developments and Future Plans
Table 35. Astellas Pharma Inc. Company Information, Head Office, and Major Competitors
Table 36. Astellas Pharma Inc. Major Business
Table 37. Astellas Pharma Inc. Next-Generation Immunology Drugs Product and Solutions
Table 38. Astellas Pharma Inc. Next-Generation Immunology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Astellas Pharma Inc. Recent Developments and Future Plans
Table 40. Bristol-Myers Squibb Company Company Information, Head Office, and Major Competitors
Table 41. Bristol-Myers Squibb Company Major Business
Table 42. Bristol-Myers Squibb Company Next-Generation Immunology Drugs Product and Solutions
Table 43. Bristol-Myers Squibb Company Next-Generation Immunology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Bristol-Myers Squibb Company Recent Developments and Future Plans
Table 45. Merck & Co., Inc. Company Information, Head Office, and Major Competitors
Table 46. Merck & Co., Inc. Major Business
Table 47. Merck & Co., Inc. Next-Generation Immunology Drugs Product and Solutions
Table 48. Merck & Co., Inc. Next-Generation Immunology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Merck & Co., Inc. Recent Developments and Future Plans
Table 50. Eli Lilly and Company Company Information, Head Office, and Major Competitors
Table 51. Eli Lilly and Company Major Business
Table 52. Eli Lilly and Company Next-Generation Immunology Drugs Product and Solutions
Table 53. Eli Lilly and Company Next-Generation Immunology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Eli Lilly and Company Recent Developments and Future Plans
Table 55. Global Next-Generation Immunology Drugs Revenue (USD Million) by Players (2018-2023)
Table 56. Global Next-Generation Immunology Drugs Revenue Share by Players (2018-2023)
Table 57. Breakdown of Next-Generation Immunology Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Next-Generation Immunology Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 59. Head Office of Key Next-Generation Immunology Drugs Players
Table 60. Next-Generation Immunology Drugs Market: Company Product Type Footprint
Table 61. Next-Generation Immunology Drugs Market: Company Product Application Footprint
Table 62. Next-Generation Immunology Drugs New Market Entrants and Barriers to Market Entry
Table 63. Next-Generation Immunology Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Next-Generation Immunology Drugs Consumption Value (USD Million) by Type (2018-2023)
Table 65. Global Next-Generation Immunology Drugs Consumption Value Share by Type (2018-2023)
Table 66. Global Next-Generation Immunology Drugs Consumption Value Forecast by Type (2024-2029)
Table 67. Global Next-Generation Immunology Drugs Consumption Value by Application (2018-2023)
Table 68. Global Next-Generation Immunology Drugs Consumption Value Forecast by Application (2024-2029)
Table 69. North America Next-Generation Immunology Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 70. North America Next-Generation Immunology Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 71. North America Next-Generation Immunology Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 72. North America Next-Generation Immunology Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 73. North America Next-Generation Immunology Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 74. North America Next-Generation Immunology Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 75. Europe Next-Generation Immunology Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Europe Next-Generation Immunology Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Europe Next-Generation Immunology Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 78. Europe Next-Generation Immunology Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 79. Europe Next-Generation Immunology Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 80. Europe Next-Generation Immunology Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 81. Asia-Pacific Next-Generation Immunology Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 82. Asia-Pacific Next-Generation Immunology Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 83. Asia-Pacific Next-Generation Immunology Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 84. Asia-Pacific Next-Generation Immunology Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 85. Asia-Pacific Next-Generation Immunology Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 86. Asia-Pacific Next-Generation Immunology Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 87. South America Next-Generation Immunology Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 88. South America Next-Generation Immunology Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 89. South America Next-Generation Immunology Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 90. South America Next-Generation Immunology Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 91. South America Next-Generation Immunology Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 92. South America Next-Generation Immunology Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Middle East & Africa Next-Generation Immunology Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 94. Middle East & Africa Next-Generation Immunology Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 95. Middle East & Africa Next-Generation Immunology Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 96. Middle East & Africa Next-Generation Immunology Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 97. Middle East & Africa Next-Generation Immunology Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 98. Middle East & Africa Next-Generation Immunology Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 99. Next-Generation Immunology Drugs Raw Material
Table 100. Key Suppliers of Next-Generation Immunology Drugs Raw Materials
Table 1. Global Next-Generation Immunology Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Next-Generation Immunology Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Next-Generation Immunology Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Next-Generation Immunology Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Pfizer Inc Company Information, Head Office, and Major Competitors
Table 6. Pfizer Inc Major Business
Table 7. Pfizer Inc Next-Generation Immunology Drugs Product and Solutions
Table 8. Pfizer Inc Next-Generation Immunology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Pfizer Inc Recent Developments and Future Plans
Table 10. Abbvie Inc. Company Information, Head Office, and Major Competitors
Table 11. Abbvie Inc. Major Business
Table 12. Abbvie Inc. Next-Generation Immunology Drugs Product and Solutions
Table 13. Abbvie Inc. Next-Generation Immunology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Abbvie Inc. Recent Developments and Future Plans
Table 15. Johnson and Johnson Company Information, Head Office, and Major Competitors
Table 16. Johnson and Johnson Major Business
Table 17. Johnson and Johnson Next-Generation Immunology Drugs Product and Solutions
Table 18. Johnson and Johnson Next-Generation Immunology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Johnson and Johnson Recent Developments and Future Plans
Table 20. F. Hoffmann-La Roche Ltd. Company Information, Head Office, and Major Competitors
Table 21. F. Hoffmann-La Roche Ltd. Major Business
Table 22. F. Hoffmann-La Roche Ltd. Next-Generation Immunology Drugs Product and Solutions
Table 23. F. Hoffmann-La Roche Ltd. Next-Generation Immunology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. F. Hoffmann-La Roche Ltd. Recent Developments and Future Plans
Table 25. Amgen Inc. Company Information, Head Office, and Major Competitors
Table 26. Amgen Inc. Major Business
Table 27. Amgen Inc. Next-Generation Immunology Drugs Product and Solutions
Table 28. Amgen Inc. Next-Generation Immunology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Amgen Inc. Recent Developments and Future Plans
Table 30. Novartis AG Company Information, Head Office, and Major Competitors
Table 31. Novartis AG Major Business
Table 32. Novartis AG Next-Generation Immunology Drugs Product and Solutions
Table 33. Novartis AG Next-Generation Immunology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Novartis AG Recent Developments and Future Plans
Table 35. Astellas Pharma Inc. Company Information, Head Office, and Major Competitors
Table 36. Astellas Pharma Inc. Major Business
Table 37. Astellas Pharma Inc. Next-Generation Immunology Drugs Product and Solutions
Table 38. Astellas Pharma Inc. Next-Generation Immunology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Astellas Pharma Inc. Recent Developments and Future Plans
Table 40. Bristol-Myers Squibb Company Company Information, Head Office, and Major Competitors
Table 41. Bristol-Myers Squibb Company Major Business
Table 42. Bristol-Myers Squibb Company Next-Generation Immunology Drugs Product and Solutions
Table 43. Bristol-Myers Squibb Company Next-Generation Immunology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Bristol-Myers Squibb Company Recent Developments and Future Plans
Table 45. Merck & Co., Inc. Company Information, Head Office, and Major Competitors
Table 46. Merck & Co., Inc. Major Business
Table 47. Merck & Co., Inc. Next-Generation Immunology Drugs Product and Solutions
Table 48. Merck & Co., Inc. Next-Generation Immunology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Merck & Co., Inc. Recent Developments and Future Plans
Table 50. Eli Lilly and Company Company Information, Head Office, and Major Competitors
Table 51. Eli Lilly and Company Major Business
Table 52. Eli Lilly and Company Next-Generation Immunology Drugs Product and Solutions
Table 53. Eli Lilly and Company Next-Generation Immunology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Eli Lilly and Company Recent Developments and Future Plans
Table 55. Global Next-Generation Immunology Drugs Revenue (USD Million) by Players (2018-2023)
Table 56. Global Next-Generation Immunology Drugs Revenue Share by Players (2018-2023)
Table 57. Breakdown of Next-Generation Immunology Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Next-Generation Immunology Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 59. Head Office of Key Next-Generation Immunology Drugs Players
Table 60. Next-Generation Immunology Drugs Market: Company Product Type Footprint
Table 61. Next-Generation Immunology Drugs Market: Company Product Application Footprint
Table 62. Next-Generation Immunology Drugs New Market Entrants and Barriers to Market Entry
Table 63. Next-Generation Immunology Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Next-Generation Immunology Drugs Consumption Value (USD Million) by Type (2018-2023)
Table 65. Global Next-Generation Immunology Drugs Consumption Value Share by Type (2018-2023)
Table 66. Global Next-Generation Immunology Drugs Consumption Value Forecast by Type (2024-2029)
Table 67. Global Next-Generation Immunology Drugs Consumption Value by Application (2018-2023)
Table 68. Global Next-Generation Immunology Drugs Consumption Value Forecast by Application (2024-2029)
Table 69. North America Next-Generation Immunology Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 70. North America Next-Generation Immunology Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 71. North America Next-Generation Immunology Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 72. North America Next-Generation Immunology Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 73. North America Next-Generation Immunology Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 74. North America Next-Generation Immunology Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 75. Europe Next-Generation Immunology Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Europe Next-Generation Immunology Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Europe Next-Generation Immunology Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 78. Europe Next-Generation Immunology Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 79. Europe Next-Generation Immunology Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 80. Europe Next-Generation Immunology Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 81. Asia-Pacific Next-Generation Immunology Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 82. Asia-Pacific Next-Generation Immunology Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 83. Asia-Pacific Next-Generation Immunology Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 84. Asia-Pacific Next-Generation Immunology Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 85. Asia-Pacific Next-Generation Immunology Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 86. Asia-Pacific Next-Generation Immunology Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 87. South America Next-Generation Immunology Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 88. South America Next-Generation Immunology Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 89. South America Next-Generation Immunology Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 90. South America Next-Generation Immunology Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 91. South America Next-Generation Immunology Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 92. South America Next-Generation Immunology Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Middle East & Africa Next-Generation Immunology Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 94. Middle East & Africa Next-Generation Immunology Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 95. Middle East & Africa Next-Generation Immunology Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 96. Middle East & Africa Next-Generation Immunology Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 97. Middle East & Africa Next-Generation Immunology Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 98. Middle East & Africa Next-Generation Immunology Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 99. Next-Generation Immunology Drugs Raw Material
Table 100. Key Suppliers of Next-Generation Immunology Drugs Raw Materials
LIST OF FIGURES
Figure 1. Next-Generation Immunology Drugs Picture
Figure 2. Global Next-Generation Immunology Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Next-Generation Immunology Drugs Consumption Value Market Share by Type in 2022
Figure 4. Cell Therapy
Figure 5. Small Molecule Drug
Figure 6. Others
Figure 7. Global Next-Generation Immunology Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Next-Generation Immunology Drugs Consumption Value Market Share by Application in 2022
Figure 9. Hospital Picture
Figure 10. Clinic Picture
Figure 11. Others Picture
Figure 12. Global Next-Generation Immunology Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Next-Generation Immunology Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market Next-Generation Immunology Drugs Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global Next-Generation Immunology Drugs Consumption Value Market Share by Region (2018-2029)
Figure 16. Global Next-Generation Immunology Drugs Consumption Value Market Share by Region in 2022
Figure 17. North America Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 20. South America Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 22. Global Next-Generation Immunology Drugs Revenue Share by Players in 2022
Figure 23. Next-Generation Immunology Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players Next-Generation Immunology Drugs Market Share in 2022
Figure 25. Global Top 6 Players Next-Generation Immunology Drugs Market Share in 2022
Figure 26. Global Next-Generation Immunology Drugs Consumption Value Share by Type (2018-2023)
Figure 27. Global Next-Generation Immunology Drugs Market Share Forecast by Type (2024-2029)
Figure 28. Global Next-Generation Immunology Drugs Consumption Value Share by Application (2018-2023)
Figure 29. Global Next-Generation Immunology Drugs Market Share Forecast by Application (2024-2029)
Figure 30. North America Next-Generation Immunology Drugs Consumption Value Market Share by Type (2018-2029)
Figure 31. North America Next-Generation Immunology Drugs Consumption Value Market Share by Application (2018-2029)
Figure 32. North America Next-Generation Immunology Drugs Consumption Value Market Share by Country (2018-2029)
Figure 33. United States Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe Next-Generation Immunology Drugs Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe Next-Generation Immunology Drugs Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe Next-Generation Immunology Drugs Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 40. France Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific Next-Generation Immunology Drugs Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific Next-Generation Immunology Drugs Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific Next-Generation Immunology Drugs Consumption Value Market Share by Region (2018-2029)
Figure 47. China Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 50. India Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 53. South America Next-Generation Immunology Drugs Consumption Value Market Share by Type (2018-2029)
Figure 54. South America Next-Generation Immunology Drugs Consumption Value Market Share by Application (2018-2029)
Figure 55. South America Next-Generation Immunology Drugs Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa Next-Generation Immunology Drugs Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa Next-Generation Immunology Drugs Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa Next-Generation Immunology Drugs Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 64. Next-Generation Immunology Drugs Market Drivers
Figure 65. Next-Generation Immunology Drugs Market Restraints
Figure 66. Next-Generation Immunology Drugs Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Next-Generation Immunology Drugs in 2022
Figure 69. Manufacturing Process Analysis of Next-Generation Immunology Drugs
Figure 70. Next-Generation Immunology Drugs Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Figure 1. Next-Generation Immunology Drugs Picture
Figure 2. Global Next-Generation Immunology Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Next-Generation Immunology Drugs Consumption Value Market Share by Type in 2022
Figure 4. Cell Therapy
Figure 5. Small Molecule Drug
Figure 6. Others
Figure 7. Global Next-Generation Immunology Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Next-Generation Immunology Drugs Consumption Value Market Share by Application in 2022
Figure 9. Hospital Picture
Figure 10. Clinic Picture
Figure 11. Others Picture
Figure 12. Global Next-Generation Immunology Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Next-Generation Immunology Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market Next-Generation Immunology Drugs Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global Next-Generation Immunology Drugs Consumption Value Market Share by Region (2018-2029)
Figure 16. Global Next-Generation Immunology Drugs Consumption Value Market Share by Region in 2022
Figure 17. North America Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 20. South America Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 22. Global Next-Generation Immunology Drugs Revenue Share by Players in 2022
Figure 23. Next-Generation Immunology Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players Next-Generation Immunology Drugs Market Share in 2022
Figure 25. Global Top 6 Players Next-Generation Immunology Drugs Market Share in 2022
Figure 26. Global Next-Generation Immunology Drugs Consumption Value Share by Type (2018-2023)
Figure 27. Global Next-Generation Immunology Drugs Market Share Forecast by Type (2024-2029)
Figure 28. Global Next-Generation Immunology Drugs Consumption Value Share by Application (2018-2023)
Figure 29. Global Next-Generation Immunology Drugs Market Share Forecast by Application (2024-2029)
Figure 30. North America Next-Generation Immunology Drugs Consumption Value Market Share by Type (2018-2029)
Figure 31. North America Next-Generation Immunology Drugs Consumption Value Market Share by Application (2018-2029)
Figure 32. North America Next-Generation Immunology Drugs Consumption Value Market Share by Country (2018-2029)
Figure 33. United States Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe Next-Generation Immunology Drugs Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe Next-Generation Immunology Drugs Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe Next-Generation Immunology Drugs Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 40. France Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific Next-Generation Immunology Drugs Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific Next-Generation Immunology Drugs Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific Next-Generation Immunology Drugs Consumption Value Market Share by Region (2018-2029)
Figure 47. China Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 50. India Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 53. South America Next-Generation Immunology Drugs Consumption Value Market Share by Type (2018-2029)
Figure 54. South America Next-Generation Immunology Drugs Consumption Value Market Share by Application (2018-2029)
Figure 55. South America Next-Generation Immunology Drugs Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa Next-Generation Immunology Drugs Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa Next-Generation Immunology Drugs Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa Next-Generation Immunology Drugs Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE Next-Generation Immunology Drugs Consumption Value (2018-2029) & (USD Million)
Figure 64. Next-Generation Immunology Drugs Market Drivers
Figure 65. Next-Generation Immunology Drugs Market Restraints
Figure 66. Next-Generation Immunology Drugs Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Next-Generation Immunology Drugs in 2022
Figure 69. Manufacturing Process Analysis of Next-Generation Immunology Drugs
Figure 70. Next-Generation Immunology Drugs Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
